Search

Author/Creator Mahoney, Michelle R.

2. North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic‐based dosing of irinotecan, oxaliplatin, and capecitabine as first‐line therapy for patients with advanced small bowel adenocarcinoma. Issue 18 (10th May 2017)

Authors:
McWilliams, Robert R.; Foster, Nathan R.; Mahoney, Michelle R.; Smyrk, Thomas C.; Murray, Joseph A.; Ames, Matthew M.; Horvath, L. Elise; Schneider, Daniel J.; Hobday, Timothy J.; Jatoi, Aminah; Meyers, Jeffrey P.; Goetz, Matthew P.
Journal:
Cancer
Issue:
Volume 123:Issue 18(2017)
Page Start:
3494
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search